SCOPUS 정보 검색 플랫폼

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 1, 2005, Pages 43-52

A comparison of four different methods for outlier detection in bioequivalence studies

(2) Ramsay, Timothy a Elkum, Naser b

a McLaughlin Ctr Pop Hlth Risk A (Canada)

b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER (Saudi Arabia)

Author keywords

Bioavailability; Bioequivalence; Outlier; Outlier detection

Indexed keywords

ANALYTIC METHOD; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; COMPUTER SIMULATION; CROSSOVER PROCEDURE; DATA ANALYSIS; DRUG DESIGN; DRUG FORMULATION; DRUG MARKETING; INTERMETHOD COMPARISON; OUTLIER DETECTION; PRIORITY JOURNAL; SYSTEMIC CIRCULATION;

CLINICAL TRIALS; CROSS-OVER STUDIES; HUMANS; THERAPEUTIC EQUIVALENCY;

EID: 12344286345 PISSN: 10543406 EISSN: None Source Type: Journal
DOI: 10.1081/BIP-200040815 Document Type: Article

Times cited : (18)

References (8)

1
- 0025359983
- Outliers detection in bioavailability/bioequivalence studies
- Cow, S. C., Tse, S. K. (1990). Outliers detection in bioavailability/ bioequivalence studies. Stat. Med. 9:549-558.
- (1990) Stat. Med. , vol.9 , pp. 549-558
- Cow, S.C.¹ Tse, S.K.²

2
- 0003455049
- New York and Basel: Marcel Dekker
- Chow, S. C., Liu, J. P. (2000). Design and Analysis of Bioavailabilily and Bioequivalence Studies. New York and Basel: Marcel Dekker.
- (2000) Design and Analysis of Bioavailabilily and Bioequivalence Studies
- Chow, S.C.¹ Liu, J.P.²

3
- 0003455044
- Rockville, Maryland: Center for Drug Evaluation and Research, Food and Drug Administration
- FDA (2000). Guideline for Industry: Bioavailabilily and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. Rockville, Maryland: Center for Drug Evaluation and Research, Food and Drug Administration.
- (2000) Guideline for Industry: Bioavailabilily and Bioequivalence Studies for Orally Administered Drug Products - General Considerations

4
- 0003922012
- Rockville, Maryland: Center for Drug Evaluation and Research, Food and Drug Administration
- FDA (2001). Statistical Approaches to Establishing Bioequivalence- Guidance for Industry. Rockville, Maryland: Center for Drug Evaluation and Research, Food and Drug Administration.
- (2001) Statistical Approaches to Establishing Bioequivalence - Guidance for Industry

5
- 0028952827
- The impact of outlying subjects on decision of bioequivalence
- Ki, F. Y. C., Liu, J. P., Wang, W., Chow, S. C. (1995). The impact of outlying subjects on decision of bioequivalence. J. Biopharm. Stat. 5(1):71-94.
- (1995) J. Biopharm. Stat. , vol.5 , Issue.1 , pp. 71-94
- Ki, F.Y.C.¹ Liu, J.P.² Wang, W.³ Chow, S.C.⁴

6
- 0025879176
- Detection of outlying data in bioavailability/bioequivalence studies
- Liu, J. P., Weng, C. S. (1991). Detection of outlying data in bioavailability/ bioequivalence studies. Stat. Med. 10:1375-1389.
- (1991) Stat. Med. , vol.10 , pp. 1375-1389
- Liu, J.P.¹ Weng, C.S.²

7
- 0016572161
- Tables for an approximate test for outliers in linear models
- Lund, R. E. (1975). Tables for an approximate test for outliers in linear models. Technometricx 17:473-476.
- (1975) Technometricx , vol.17 , pp. 473-476
- Lund, R.E.¹

8
- 0037284914
- Examining outlying subjects and outlying records in bioequivalence trials
- Wang, W., Chow, S. C. (2003). Examining outlying subjects and outlying records in bioequivalence trials. J. Biopharm. Stat. 13(1):43-56.
- (2003) J. Biopharm. Stat. , vol.13 , Issue.1 , pp. 43-56
- Wang, W.¹ Chow, S.C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.